SSO Education Series: Evidence Today and Tomorrow – Pancreatic Cystic Neoplasms
Release Date: 01/21/2026
SurgOnc Today®
In this series “evidence today and tomorrow”, the HPB disease site working group of the SSO explores current gaps in HPB surgical oncology, highlighting existing evidence and ongoing work aimed at filling those gaps. In this episode, Drs. Julie Hallet and Patricio Polanco, chair and vice-chair of the HPB disease site working group are joined by Drs. Ajay Maker, Rebecca Snyder, and Giovanni Marchegiani to review evidence in the management of pancreatic cystic neoplasms.
info_outlineSurgOnc Today®
In this episode of SurgOnc Today, Dr. Zhi Ven Fong, of the HPB Disease Site Work Group interviews Dr. Yorick L. van de Pavert about the ENDURO Trial's (surgical vs endoscopic gastrojejunostomy bypass) design, implementation, and primary and secondary endpoints. If you did not check out part 1, please be sure to visit SurgOnc Academy for the full series: https://learn.surgonc.org/courses/112569
info_outlineSurgOnc Today®
In this episode of SurgOnc Today, we discuss the recently updated ASCO guidelines for axillary staging with sentinel lymph node biopsy in breast cancer, as well as considerations for their application in a multidisciplinary setting. This episode is moderated by Dr. Ashley Woodfin from the University of Wisconsin, who is joined by Dr. Clara Park from Brigham and Women’s Hospital and Dr. Andrea Abbott from Medical University of South Carolina for a in-depth discussion regarding the guidelines implementation and important considerations.
info_outlineSurgOnc Today®
In this episode of Outside the OR, we explore how collaboration between the Society of Surgical Oncology (SSO) and the American College of Surgeons Cancer Surgery Standards Program (ACS CSSP) is helping raise the bar for cancer care nationwide. Joined by Dr. Matthew H.G. Katz and Dr. Tina J. Hieken, we discuss how shared standards, multidisciplinary alignment, and surgeon leadership translate into better support for surgeons, and better outcomes for patients. Tune in for a thoughtful conversation on why collaboration matters and how collective efforts are shaping the future of cancer...
info_outlineSurgOnc Today®
In this new episode of Speaking of SurgOnc, Dr. Rick Greene and Dr. Shayna Showalter discuss recently updated considerations by the SSO Breast Task Force regarding bilateral and contralateral risk-reducing mastectomy, highlighting important considerations for clinical practice, as reported in the editorial, "Highlights and Perspectives from The Society of Surgical Oncology's Statements on Bilateral and Contralateral Risk-Reducing Mastectomy."
info_outlineSurgOnc Today®
In this episode of SurgOnc Today's Surgical Oncology Insight series, Dr. Monisha Sudarshan, Section Editor of the Thoracic Editorial Board section, discusses with Dr. Erin A. Gillaspie her paper “Immunotherapy in gastroesophageal adenocarcinoma: What is the state of management?".
info_outlineSurgOnc Today®
In this episode of SurgOnc Today, Casey Allen leads a discussion with Oluwadamilola Fayanju, Laura Dominici, Michael Egger, Cristina O’Donoghue, and Winta Mehtsun, exploring how value-based care principles intersect with access, equity, and health policy in surgical oncology. The conversation highlights social determinants of health, rural outreach, and global initiatives advancing high-quality, value-based cancer surgery.
info_outlineSurgOnc Today®
In this episode, join the SSO HPB disease site working group as they count down the first five studies in the 2025 HPB wrapped. This episode dives into some of the year’s most practice-changing publications in HPB surgical oncology: the Preopanc-2 Trial, the Collision Trial, the Tesla trial, the use of Kras in ablation for Colorectal Liver Metastases, and the ENDURO Trial. Hear our guests Dr. Sandra DiBrito and Dr. Neha Lad as they review the studies and unpack what these findings mean for clinical practice.
info_outlineSurgOnc Today®
In this episode, join the SSO HPB disease site working group as they count down the final five studies in the 2025 HPB wrapped. This episode dives into some of the year’s most practice-changing publications in HPB surgical oncology: the ROC’N’ROLL Trial, best practices neoadjuvant therapy for pancreas cancer, the PANDRA-II Trial, the use of SBRT for resectable pancreas cancer, and the PREHEP Trial. Hear our guests Dr. Colin Court and Dr. Winnie Lo as they review the studies and unpack what these findings mean for clinical practice.
info_outlineSurgOnc Today®
Family planning and fertility preservation can pose challenges for trainees and new surgical oncology attendings. The SSO Fellows and Young Attendings Committee tackles these topics within a three-part podcast. On this episode of SurgOnc Today, hosts Dr. Danielle Graham and Dr. Paige Aiello discuss fertility preservation techniques and other considerations with reproductive endocrinologist Dr. Nicole Budrys and surgeons Dr. Alisa Blumenthaler and Dr. Jordan Jackson.
info_outlineIn this series “evidence today and tomorrow”, the HPB disease site working group of the SSO explores current gaps in HPB surgical oncology, highlighting existing evidence and ongoing work aimed at filling those gaps. In this episode, Drs. Julie Hallet and Patricio Polanco, chair and vice-chair of the HPB disease site working group are joined by Drs. Ajay Maker, Rebecca Snyder, and Giovanni Marchegiani to review evidence in the management of pancreatic cystic neoplasms.